XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. It also provides electric and gas fusion machines, flux weighing, fusion flux, and fusion labware products; reference materials, including drift monitors, fused calibration beads, and synthetic iron ore; pressing consumables and xrTab binder tablets; zirconium crucibles; laboratory jaw crushers and containerised laboratories; press and pellet press dies; water dispensing systems; platinum beakers, crucibles, and dishes; and platinum products, such as electrodes, ICP components, customised platinum components, and semi-finished products. In addition, the company offers instruments comprising thermogravimetric analysis; CGA elemental analysers; pH, conductivity, and acid base titration; and weighing systems, as well as product recycling services. XRF Scientific Limited was founded in 1972 and is based in Osborne Park, Australia.
Price analytics
Returns
1 day
1.1%
1 week
2.9%
1 month
-4.5%
3 months
1.7%
6 months
-1.6%
1 year
-20.7%
3 years
80.0%
Risk
Volatility (1y ann.)
41.2%
Beta vs ASX 200
0.86
Sharpe (1y)
-0.46
VaR 95% (1-day)
-3.9%
Max drawdown (1y)
-29.7%
Off 1-year high
-22.1%
Technicals
RSI(14)
51
vs 50DMA
-0.3%
vs 200DMA
-2.5%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value50.2
Trailing P/E
45
Forward P/E
63
PEG ratio
—
EV / EBITDA
30
Price / Book
57
Price / Sales
65
Growth60.1
Revenue growth (1y)
52
Revenue CAGR (3y)
41
EPS growth (1y)
71
EPS CAGR (3y)
80
Financial Health100.0
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)93.8
Return on equity
83
Return on assets
100
Operating margin
96
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income57.2
Dividend yield (%)
42
Payout ratio
73
FCF dividend cover
56
Momentum49.6
6-month return vs ASX 200
73
Price vs 200-day average
42
Price vs 50-day average
48
Position in 52-week range
26
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).